CompletedNot Applicable

Transdisciplinary Intervention for Obesity Hypoventilation Syndrome

Taiwan36 participantsStarted 2022-09-01

Plain-language summary

The aims of this prospective observational cohort study are threefold: (1) to assess the prevalence of obesity hypoventilation syndrome (OHS) in individuals with obesity and obstructive sleep apnea (OSA) and identify associated risk factors, (2) to determine clinical predictors of OHS, and (3) to evaluate the therapeutic outcomes of combined airway and bariatric surgery (CABS) in this population.

Who can participate

Age range20 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: (1) BMI ≥ 30 kg/m², and (2) AHI ≥ 5 events/hour. Exclusion Criteria: (1) persistent decompensated hypercapnic respiratory failure (arterial pH \< 7.3), (2) acute respiratory failure requiring invasive mechanical ventilation, (3) significant neuromuscular disease, chest wall deformities, or pulmonary disease contributing to hypoventilation, (4) unstable coronary artery disease, or (5) cognitive impairment precluding informed consent or protocol adherence.

What they're measuring

AHI

Timeframe: From enrollment to the end of treatment at 12 months.

Trial details

NCT IDNCT07020689

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-31

View on ClinicalTrials.gov More Obesity Hypoventilation Syndrome (OHS) trials